Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of 4 mg methylprednisolone tablets in fed Chinese healthy volunteers
CTR20223197Phase 4Completed
- Sponsor
- Puyang Huiyuan Pharmaceutical
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in conditions requiring systemic glucocorticoid therapy, sponsored by Puyang Huiyuan Pharmaceutical. Started Dec 2022; status: completed.
02
Drugs
methylprednisolone
03
Conditions
conditions requiring systemic glucocorticoid therapy
Beyond the preview
Go deeper on CTR20223197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223197.